TOMARALIMAB

UNII: P45C2W27DU
Preferred Substance Name: TOMARALIMAB

1449294-76-1
ANTI-TLR2 MONOCLONAL ANTIBODY OPN-305
HUMANIZED IGG4 MONOCLONAL ANTIBODY AGAINST TOLL-LIKE RECEPTOR 2 FOR PREVENTION OF ISCHEMIA/REPERFUSION TISSUE INJURY
IMMUNOGLOBULIN G4, ANTI-(HUMAN TOLL-LIKE RECEPTOR TLR-2) (HUMAN-MUS MUSCULUS MONOCLONAL OPN-305 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OPN-305 LIGHT CHAIN, DIMER
OPN-305
TOMARALIMAB [INN]
TOMARALIMAB [USAN]
TOMARALIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TOMARALIMAB

Synonyms and Mappings

Resources

Note